Alaunos Therapeutics
TCRT
TCRT
156 hedge funds and large institutions have $281M invested in Alaunos Therapeutics in 2020 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 40 increasing their positions, 53 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
156
Holders Change
+2
Holders Change %
+1.3%
% of All Funds
2.77%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
27
Increased
40
Reduced
53
Closed
25
Calls
$2.72M
Puts
$2.51M
Net Calls
+$207K
Net Calls Change
-$452K
Top Buyers
| 1 |
1
BlackRock
New York
|
$46.8M |
| 2 |
DCM
2
Discovery Capital Management
South Norwalk,
Connecticut
|
$30.2M |
| 3 |
3
JPMorgan Chase & Co
New York
|
$6.59M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$40.2M |
| 5 |
5
Two Sigma Advisers
New York
|
$2.24M |
Top Sellers
| 1 |
1
Goldman Sachs
New York
|
$1.04M |
| 2 |
2
SG Americas Securities
New York
|
$1.36M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$22.1M |
| 4 |
4
Bank of America
Charlotte,
North Carolina
|
$1.04M |
| 5 |
TRCT
5
Tower Research Capital (TRC)
New York
|
$51K |
